Lalwani Nikhil (CIK 1822629) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Sell ANIP (55,000 shares), Sell ANIP (17,060 shares), Buy ANIP (75,592 shares), Sell ANIP (12,217 shares), Sell ANIP (11,688 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 55,000 | $4.3M |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 17,060 | $1.3M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Buy | 75,592 | $5.8M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 12,217 | $902,836 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 11,688 | $896,470 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 10,298 | $796,653 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 30,659 | $2.3M |
| 2025-08-14 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 56,960 | $4.9M |
| 2025-03-25 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 17,455 | $1.1M |
| 2025-03-14 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 17,060 | $1.0M |
| 2025-03-04 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 12,216 | $756,048 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Buy | 91,399 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Buy | 60,932 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 7,799 | $459,517 |
Source: SEC Form 4 filings · as of 2026-05-13